D-1179-2017 Class III Terminated
FDA drug recall D-1179-2017 was initiated by Sandoz Inc on Sep 25, 2017 and is designated Class III. Reason for recall: Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels. The recall status is terminated (terminated Apr 8, 2019). Affected quantity: 13,435 shrink wrap packs.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 4, 2017
- Initiation Date
- Sep 25, 2017
- Termination Date
- Apr 8, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 13,435 shrink wrap packs
Product description
Ampicillin for Injection, USP, 500 mg per vial, single vial (NDC 0781-3407-78) packaged in 10-count shrink wrap packs (NDC 0781-3407-95), Rx only, Manufactured in Austria by Sandoz GmbH or Sandoz Inc., Princeton, NJ 08540.
Reason for recall
Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels.
Distribution pattern
Nationwide in the USA and Puerto Rico
Code information
Lot: GH8254, Exp 06/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1179-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026